OrthoPediatrics Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 OrthoPediatrics Corp 公司

OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.

OrthoPediatrics Corp簡介



公司代碼KIDS

公司名稱OrthoPediatrics Corp

上市日期Oct 12, 2017

CEOBailey (David R)

員工數量562

證券類型Ordinary Share

年結日Oct 12

公司地址2850 Frontier Drive

城市WARSAW

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編46582

電話15742686379

網址https://www.orthopediatrics.com/

公司代碼KIDS

上市日期Oct 12, 2017

CEOBailey (David R)

OrthoPediatrics Corp公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. David R. Bailey

President, Chief Executive Officer, Director

298.02K

--

Mr. Fred L. Hite

Chief Financial Officer, Chief Operating Officer, Director

277.48K

--

Mr. Joseph W. Hauser

President of Trauma, Deformity and OPSB

194.77K

--

Mr. Mark C. Throdahl

Chairman of the Board

190.38K

--

Mr. Gregory A. Odle

President of Scoliosis

187.74K

--

Mr. David R. Pelizzon

Independent Director

32.95K

--

Mr. Bryan W. Hughes

Independent Director

21.23K

--

Mr. Samuel D. Riccitelli

Independent Director

20.42K

--

Ms. Marie C. Infante, J.D.

Independent Director

19.77K

--

Ms. Kelly Fischer

Director

4.34K

--

名稱

名稱/職務

職務

持股

持股變動

Mr. David R. Bailey

President, Chief Executive Officer, Director

298.02K

--

Mr. Fred L. Hite

Chief Financial Officer, Chief Operating Officer, Director

277.48K

--

Mr. Joseph W. Hauser

President of Trauma, Deformity and OPSB

194.77K

--

Mr. Mark C. Throdahl

Chairman of the Board

190.38K

--

Mr. Gregory A. Odle

President of Scoliosis

187.74K

--

Mr. David R. Pelizzon

Independent Director

32.95K

--

收入明細

單位: USD更新時間: 4月6日週一

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

Trauma and Deformity

166.30M

70.36%

Scoliosis

66.05M

27.94%

Sports Medicine and Other

4.00M

1.69%

地區USD

名稱

營收

佔比

U.S.

186.40M

78.87%

International

49.95M

21.13%

業務

地區

業務USD

名稱

營收

佔比

Trauma and Deformity

166.30M

70.36%

Scoliosis

66.05M

27.94%

Sports Medicine and Other

4.00M

1.69%

股東統計

更新時間: 5月10日週日

持股股東

股東類型

持股股東

佔比

Squadron Capital LLC

26.87%

Brown Advisory

7.36%

Millennium Management LLC

5.44%

Braidwell LP

4.28%

BlackRock Institutional Trust Company, N.A.

4.21%

其他

51.83%

持股股東

佔比

Squadron Capital LLC

26.87%

Brown Advisory

7.36%

Millennium Management LLC

5.44%

Braidwell LP

4.28%

BlackRock Institutional Trust Company, N.A.

4.21%

其他

51.83%

股東類型

持股股東

佔比

Corporation

26.87%

Investment Advisor/Hedge Fund

25.17%

Investment Advisor

21.41%

Hedge Fund

15.72%

Individual Investor

5.77%

Research Firm

4.75%

Venture Capital

0.47%

Bank and Trust

0.11%

Pension Fund

0.05%

機構持股



更新時間: 4月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2026Q1

287

18.35M

71.44%

-360.87K

2025Q4

286

17.69M

70.55%

-1.38M

2025Q3

290

16.80M

66.98%

-2.63M

2025Q2

307

26.06M

103.94%

-977.48K

2025Q1

321

26.03M

105.09%

-1.19M

2024Q4

319

25.60M

105.70%

-1.27M

2024Q3

325

25.26M

104.34%

-2.01M

2024Q2

325

25.18M

104.01%

-1.27M

2024Q1

329

24.43M

104.11%

-1.85M

2023Q4

333

24.59M

105.32%

-1.43M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Squadron Capital LLC

6.90M

27.3%

--

Mar 28, 2025

Brown Advisory

1.89M

7.48%

-3.82K

-0.20%

Dec 31, 2025

Millennium Management LLC

1.40M

5.52%

+5.84K

+0.42%

Dec 31, 2025

Braidwell LP

1.10M

4.35%

-7.40K

-0.67%

Dec 31, 2025

BlackRock Institutional Trust Company, N.A.

1.08M

4.28%

-4.73K

-0.44%

Dec 31, 2025

Wellington Management Company, LLP

1.02M

4.03%

-4.86K

-0.47%

Dec 31, 2025

Morgan Stanley & Co. LLC

881.82K

3.49%

-217.17K

-19.76%

Dec 31, 2025

Granahan Investment Management, LLC

663.98K

2.63%

-95.97K

-12.63%

Dec 31, 2025

Dimensional Fund Advisors, L.P.

622.42K

2.46%

-97.41K

-13.53%

Dec 31, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

Invesco NASDAQ Future Gen 200 ETF

0.42%

State Street SPDR S&P Health Care Equipment ETF

0.39%

SPDR SSGA US Small Cap Low Volatility Index ETF

0.09%

iShares Micro-Cap ETF

0.06%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.04%

Avantis US Small Cap Equity ETF

0.03%

WisdomTree US SmallCap Fund

0.02%

Humankind US Stock ETF

0.01%

Proshares Ultra Russell 2000

0.01%

ProShares UltraPro Russell2000

0.01%

Invesco NASDAQ Future Gen 200 ETF

佔比0.42%

State Street SPDR S&P Health Care Equipment ETF

佔比0.39%

SPDR SSGA US Small Cap Low Volatility Index ETF

佔比0.09%

iShares Micro-Cap ETF

佔比0.06%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.04%

Avantis US Small Cap Equity ETF

佔比0.03%

WisdomTree US SmallCap Fund

佔比0.02%

Humankind US Stock ETF

佔比0.01%

Proshares Ultra Russell 2000

佔比0.01%

ProShares UltraPro Russell2000

佔比0.01%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

除權除息日

類型

比率

暫無數據

公告日期

除權除息日

類型

比率

暫無數據